Concord Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Concord Biotech Ltd. on BSE

Load latest

Concord Biotech Ltd.

07 Jun 2024

1657.70

-0.66%

Corp. Note

Concord Biotech Ltd - 543960 - Reg. 34 (1) Annual Report.

BSE India

Annual report-Disclosure under regulation 34 of SEBI (LODR) regulation, 2015

pdf

Concord Biotech Ltd.

07 Jun 2024

1657.70

-0.66%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to regulation 30 of SEBI (LODR), please find the enclosed notices given to shareholders in accordance with applicable provision of SEBI listing regulation and the companies Act 2013 read with rules made thereunder, inter alia, informing them about 39th annual general meeting of the company and details relating to e-voting facility.

pdf

Concord Biotech Ltd.

05 Jun 2024, 07:41PM

1657.70

-0.66%

Company Update

Concord Biotech Ltd - 543960 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Intimation about EUGMP Certificate issued by Health Product Regulatory Authority of Ireland for Valthera Facility (Unit II) of the Company. Kindly take the above information on record.

pdf

Concord Biotech Ltd.

04 Jun 2024, 11:32AM

1657.70

-0.66%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Analyst/ Institutional Investor Meetings under SEBI (LODR) regulation, 2015

pdf

Concord Biotech Ltd.

04 Jun 2024, 11:12AM

1657.70

-0.66%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcripts of Q4 & FY24 Earning call Held on May 28, 2024

pdf

Concord Biotech Ltd.

29 May 2024

1657.70

-0.66%

SAST

Concord Biotech Ltd - 543960 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for 1575773 Ontario INC

pdf

Concord Biotech Ltd.

28 May 2024

1657.70

-0.66%

Company Update

Concord Biotech Ltd - 543960 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to the regulation 24A of the SEBI (LODR) Regulation (Amendment), 2018, Please find the enclosed annual secretarial compliance report for the year ended March 31, 2024. Kindly take the above on records.

pdf

Concord Biotech Ltd.

28 May 2024

1657.70

-0.66%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated May 21, 2024 to the Stock exchanges regarding Earning call in respect of the audited (Standalone and Consolidated) Financial Results of the company for the fourth Quarter and year ended March 31, 2024, we wish to inform that the said Earning Call was held today at 04:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q4FY24-earning-call-audio.mp3 Kindly take the above on records.

pdf

Concord Biotech Ltd.

27 May 2024

1657.70

-0.66%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to regulation 30 of schedule III Part A (LODR) regulation 2015, Investor Presentation on financial results for the fourth quarter and year ended March 31, 2024 is enclosed. Kindly take the above on records.

pdf

Concord Biotech Ltd.

24 May 2024

1657.70

-0.66%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to regulation of the SEBI (LODR) regulation, 2015, Please find the enclosed herewith the extracts of standalone and consolidated audited financial results for fourth quarter and year ended March 31, 2024 as published in Various Newspaper on May 24, 2024. Kindly take the above on records.

pdf